prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Specimen #: Race: BLACK. Physician (s) : AMENDED ICD-0-3. SPECIMEN: LEFT BREAST MASS. FINAL DIAGNOSIS: BREAST, LEFT, BIOPSY: POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA (GRADE III/III PER. MODIFIED BLOOM RICHARDSON GRADING) WITH EXTENSIVE NECROSIS. TUMOR SIZE = 3.0 CM (MEASURED GROSSLY). MINIMAL IN-SITU COMPONENT (HIGH GRADE). LYMPHVASCULAR SPACE INVASION IS IDENTIFIED. TUMOR EXTENDS TO WITHIN 1 MM OF THE DEEP SURGICAL MARGIN. HYALINIZED FIBROADENOMA. COMMENT: Dr. was notified of the above diagnosis via e-mail on. ESTROGEN AND PROGESTERONE RECEPTORS WERE PERFORMED. THE TUMOR IS NEGATIVE. FOR ESTROGEN RECEPTORS AND FOCALLY POSITIVE FOR PROGESTERONE RECEPTORS. HER2/neu BY IMMUNOHISTOCHEMISTRY (HERCEPTEST) : NEGATIVE (0+) . CLINICAL DIAGNOSIS AND HISTORY: (None Given}. GROSS DESCRIPTION: LEFT BREAST MASS received fresh and consists of a fibrofatty tissue. fragment measuring 8.0 x 2.5 x 2.3 cm. The deep margin is designated with. a suture. The deep margin is inked black, while the remainder of the. specimen is inked blue. At the deep margin there is a firm,. well-circumscribed - mass measuring 3.0 x 2.5 x 2.5 cm with a tan, gritty,. and focally hemorrhagic cut surface. The remaining tissue is predominantly. Specimen #: GROSS DESCRIPTION (continued) : fatty and unremarkable. Multiple sections of tumor and grossly normal. breast tissue are harvested for CBCP protocol. Mirror images for histology. are as follows : A1-Tumor. A2-Tumor. A3-Gross normal. Additional sections are as follows: A4-10-Tumor. -. A11-12-Gross normal.

expanded version (tokens=855) : 
 The breast pathology report describes a poorly differentiated invasive ductal carcinoma (grade III/III per modified Bloom Richardson grading) with extensive necrosis, measuring 3.0 cm in size. The tumor shows minimal in-situ component (high grade) and lymphovascular space invasion. The report also mentions that the tumor extends to within 1 mm of the deep surgical margin and that hyalinized fibroadenoma is present. 

The histological classification of the cancer is invasive ductal carcinoma, and the subtype is basal. The report also indicates that there is a minimal in-situ component (high grade). 

The tumor is poorly differentiated (grade III/III per modified Bloom Richardson grading) and has extensive necrosis. Tumor infiltrating lymphocytes are not mentioned in the report.

Lymphovascular space invasion is identified in the tumor. The tumor extends to within 1 mm of the deep surgical margin.

Receptor status testing was performed, which determined that the tumor is negative for estrogen receptors and focally positive for progesterone receptors. HER2/neu testing by immunohistochemistry (HERCEPTEST) was negative (0+).

The report does not mention any findings related to calcification or other ancillary testing results, but notes that multiple sections of tumor and grossly normal breast tissue are harvested for CBCP protocol.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1010) : 
 The report identifies a basal subtype invasive ductal carcinoma with extensive necrosis, measuring 3.0 cm in size. It has minimal in-situ component (high grade) and lymphovascular space invasion. Receptor status testing revealed that the tumor is negative for estrogen receptors and focally positive for progesterone receptors, with a HER2/neu score of negative (0+). Tumor infiltrating lymphocytes are not mentioned in the report, and there were no findings related to calcification or other ancillary testing results.

